Insider trades
Guggenhime Andrew, CFO of Vaxcyte PCVX, has filed 0 purchases and 46 sales on the open market. Over the past 12 months that comes to a net sale of $530K. The latest trade was on 06/18.
Guggenhime Andrew
President and CFO
- Company
- Vaxcyte PCVX
- First filing
- 23/01/04
- Trades
- 126 trades
- Buys / sales
- 0 / 46
- 12-month net buying
- −$530K
- Last trade
- 06/18
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
VaxcytePCVX | Open-market sale10b5-1 plan | 06/18 | 06/18 | 10,000 sh | $53.00 | $530,000 | −8.7% |
PCVX | Open-market sale10b5-1 plan | 25/02/18 | 25/02/19 | 8,000 sh2 trades | $83.85avg. | $670,828.92 | −6.8% |
PCVX | Open-market sale10b5-1 plan | 25/01/21 | 25/01/22 | 8,000 sh3 trades | $86.51avg. | $692,085.29 | −6.8% |
PCVX | Open-market sale10b5-1 plan | 24/12/18 | 24/12/19 | 8,000 sh4 trades | $88.78avg. | $710,243.37 | −6.8% |
PCVX | Open-market sale10b5-1 plan | 24/11/18 | 24/11/19 | 8,000 sh3 trades | $85.82avg. | $686,555.13 | −6.8% |
PCVX | Open-market sale10b5-1 plan | 24/10/18 | 24/10/22 | 42,000 sh2 trades | $115.39avg. | $4,846,393.98 | −31.7% |
PCVX | Open-market sale10b5-1 plan | 24/09/18 | 24/09/19 | 8,000 sh3 trades | $115.95avg. | $927,563.31 | −8.1% |
PCVX | Open-market sale10b5-1 plan | 24/08/19 | 24/08/20 | 8,000 sh2 trades | $78.58avg. | $628,675.34 | −7.6% |
PCVX | Open-market sale10b5-1 plan | 24/07/18 | 24/07/22 | 8,000 sh4 trades | $81.17avg. | $649,360.32 | −7.6% |
PCVX | Open-market sale10b5-1 plan | 24/06/18 | 24/06/20 | 8,000 sh2 trades | $71.92avg. | $575,353.16 | −7.6% |
PCVX | Open-market sale10b5-1 plan | 24/05/20 | 24/05/22 | 8,000 sh2 trades | $74.99avg. | $599,923.36 | −7.7% |
PCVX | Open-market sale10b5-1 plan | 24/04/18 | 24/04/22 | 8,000 sh2 trades | $61.27avg. | $490,168.16 | −7.7% |
PCVX | Open-market sale10b5-1 plan | 24/03/18 | 24/03/20 | 8,000 sh2 trades | $69.02avg. | $552,151.04 | −7.7% |
PCVX | Open-market sale10b5-1 plan | 24/02/20 | 24/02/22 | 8,000 sh3 trades | $74.53avg. | $596,223.39 | −9.1% |
PCVX | Open-market sale10b5-1 plan | 24/01/18 | 24/01/19 | 8,000 sh4 trades | $60.74avg. | $485,896.98 | −9.1% |
PCVX | Open-market sale10b5-1 plan | 23/12/18 | 23/12/20 | 8,000 sh2 trades | $60.18avg. | $481,432.54 | −9.1% |
VaxcytePCVX | Open-market sale10b5-1 plan | 23/12/14 | 23/12/18 | 14,000 sh | $60.22 | $843,080 | −15.0% |
PCVX | Open-market sale10b5-1 plan | 23/11/20 | 23/11/22 | 8,000 sh2 trades | $51.13avg. | $409,062.92 | −9.1% |
PCVX | Open-market sale10b5-1 plan | 23/10/18 | 23/10/20 | 8,000 sh2 trades | $45.92avg. | $367,336.29 | −9.1% |